Vanguard Group Inc Eledon Pharmaceuticals, Inc. Transaction History

Vanguard Group Inc

$5.97 Trillion
Q2 2025

A detailed history of Vanguard Group Inc transactions in Eledon Pharmaceuticals, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 3,318,383 shares of ELDN stock, worth $9.46 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

3,318,383

Previous 2,953,127 12.37%

Holding current value

$9.46 Million

Previous $10 Million 10.18%

% of portfolio

0.0%

Previous 0.0%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 11, 2025	BUY	$2.6 - $3.36 $949,665 - $1.23 Million	365,256 Added 12.37%	3,318,383 $8.99 Million
Q1 2025 May 09, 2025	BUY	$3.35 - $4.83 $195,934 - $282,497	58,488 Added 2.02%	2,953,127 $10 Million
Q4 2024 Feb 11, 2025	BUY	$2.45 - $5.3 $3.26 Million - $7.04 Million	1,329,152 Added 84.9%	2,894,639 $11.8 Million
Q3 2024 Nov 13, 2024	BUY	$2.41 - $3.19 $1.11 Million - $1.47 Million	461,092 Added 41.75%	1,565,487 $3.9 Million
Q2 2024 Aug 13, 2024	BUY	$1.57 - $3.12 $212,380 - $422,054	135,274 Added 13.96%	1,104,395 $2.92 Million
Q1 2024 May 10, 2024	BUY	$1.54 - $2.13 $421,502 - $582,987	273,703 Added 39.36%	969,121 $2 Million
Q4 2023 Feb 14, 2024	BUY	$1.12 - $1.86 $23,405 - $38,870	20,898 Added 3.1%	695,418 $1.25 Million
Q3 2023 Nov 14, 2023	SELL	$1.14 - $1.66 $5,742 - $8,361	-5,037 Reduced 0.74%	674,520 $924,000
Q4 2022 Feb 10, 2023	BUY	$2.17 - $2.75 $681 - $863	314 Added 0.05%	679,557 $1.55 Million
Q1 2022 May 13, 2022	BUY	$3.06 - $4.89 $29,201 - $46,665	9,543 Added 1.42%	679,243 $2.68 Million
Q4 2021 Feb 14, 2022	SELL	$4.02 - $6.07 $3,268 - $4,934	-813 Reduced 0.12%	669,700 $2.95 Million
Q3 2021 Nov 12, 2021	BUY	$5.94 - $8.46 $2.74 Million - $3.9 Million	460,763 Added 219.67%	670,513 $4.14 Million
Q2 2021 Aug 13, 2021	BUY	$7.62 - $11.75 $1.6 Million - $2.46 Million	209,750 New	209,750 $1.66 Million

Others Institutions Holding ELDN

# of Institutions

Shares Held

36.8M

Call Options Held

48.5K

Put Options Held

30.3K

View Full List

About Eledon Pharmaceuticals, Inc.

Ticker ELDN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,756,800
Market Cap $39.2M
Description
Eledon Pharmaceuticals, Inc., clinical stage biopharmaceutical company, focuses on developing medicines for the patients living with autoimmune disease and amyotrophic lateral sclerosis (ALS), and requiring an organ or cell-based transplant. Its lead product candidate includes AT-1501, a humanized monoclonal antibody to target CD40 Ligand that i...

More about ELDN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.

Account

Vanguard Group Inc Eledon Pharmaceuticals, Inc. Transaction History